Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes-Reference-Cited by-同舟云学术

Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes

Published:2022-01-18 Issue:2 Volume:53 Page:363-371
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Usman Abira,Bliden Kevin P.,Cho Alastair,Walia Naval,Jerjian Christophe,Singh Arvind,Kundan Parshotam,Duhan Sanchit,Tantry Udaya S.,Gurbel Paul A.^ORCID

Funder

Platelet and Thrombosis Research

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

https://link.springer.com/content/pdf/10.1007/s11239-022-02631-7.pdf

Reference44 articles.

1. Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S (2020) COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol 8:782–792

2. Viswanathan V, Puvvula A, Jamthikar AD et al (2021) Bidirectional link between diabetes mellitus and coronavirus disease 2019 leading to cardiovascular disease: a narrative review. World J Diabetes 12:215–237

3. Petrilli CM, Jones SA, Yang J (2020) Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City. BMJ 369:1966

4. Roncon L, Zuin M, Rigatelli G, Zuliani G (2020) Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome. J Clin Virol 127:104354

5. Saha S, Al-Rifai RH, Saha S (2021) Diabetes prevalence and mortality in COVID-19 patients: a systematic review, meta-analysis, and meta-regression. J Diabetes Metab Disord 1–12

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action;Heliyon;2024-08

2. Influence of Metformin Discontinuation on Readmission Rate in Patients with Acute Heart Failure;Journal of Community Hospital Internal Medicine Perspectives;2024-07-02

3. Metformin is a potential therapeutic for COVID-19/LUAD by regulating glucose metabolism;Scientific Reports;2024-05-30

4. Frequency of Mortality and Adverse Outcomes of COVID-19 in Hospitalized Type 2 Diabetics with a History of Sitagliptin or Metformin Use;Jundishapur Journal of Chronic Disease Care;2024-05-07

5. The Effect of Antihyperglycemic Medications on COVID-19: A Meta-analysis and Systematic Review from Observational Studies;Therapeutic Innovation & Regulatory Science;2024-04-29